![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TNNT3 |
Gene summary for TNNT3 |
![]() |
Gene information | Species | Human | Gene symbol | TNNT3 | Gene ID | 7140 |
Gene name | troponin T3, fast skeletal type | |
Gene Alias | DA2B2 | |
Cytomap | 11p15.5 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | P45378 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7140 | TNNT3 | LZE8T | Human | Esophagus | ESCC | 3.19e-08 | 4.89e-01 | 0.067 |
7140 | TNNT3 | P8T-E | Human | Esophagus | ESCC | 8.56e-12 | 2.67e-01 | 0.0889 |
7140 | TNNT3 | P10T-E | Human | Esophagus | ESCC | 1.78e-03 | 1.37e-01 | 0.116 |
7140 | TNNT3 | P20T-E | Human | Esophagus | ESCC | 1.51e-02 | 9.49e-02 | 0.1124 |
7140 | TNNT3 | P54T-E | Human | Esophagus | ESCC | 9.92e-04 | 1.91e-01 | 0.0975 |
7140 | TNNT3 | P62T-E | Human | Esophagus | ESCC | 8.76e-11 | 3.82e-01 | 0.1302 |
7140 | TNNT3 | P79T-E | Human | Esophagus | ESCC | 2.39e-24 | 9.22e-01 | 0.1154 |
7140 | TNNT3 | P80T-E | Human | Esophagus | ESCC | 3.35e-21 | 7.79e-01 | 0.155 |
7140 | TNNT3 | P89T-E | Human | Esophagus | ESCC | 4.36e-04 | 5.44e-01 | 0.1752 |
7140 | TNNT3 | P128T-E | Human | Esophagus | ESCC | 1.91e-31 | 1.18e+00 | 0.1241 |
7140 | TNNT3 | P130T-E | Human | Esophagus | ESCC | 9.20e-06 | 1.71e-01 | 0.1676 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003103219 | Esophagus | ESCC | actomyosin structure organization | 108/8552 | 196/18723 | 4.86e-03 | 1.88e-02 | 108 |
GO:00434627 | Esophagus | ESCC | regulation of ATPase activity | 30/8552 | 46/18723 | 5.91e-03 | 2.18e-02 | 30 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TNNT3 | SNV | Missense_Mutation | novel | c.694N>G | p.Arg232Gly | p.R232G | P45378 | protein_coding | deleterious(0.03) | possibly_damaging(0.848) | TCGA-BG-A221-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TNNT3 | SNV | Missense_Mutation | rs76655120 | c.296G>A | p.Arg99His | p.R99H | P45378 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
TNNT3 | SNV | Missense_Mutation | c.291N>T | p.Glu97Asp | p.E97D | P45378 | protein_coding | deleterious(0.05) | possibly_damaging(0.686) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TNNT3 | SNV | Missense_Mutation | novel | c.183N>T | p.Lys61Asn | p.K61N | P45378 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TNNT3 | SNV | Missense_Mutation | rs755730812 | c.548N>A | p.Arg183His | p.R183H | P45378 | protein_coding | deleterious(0.02) | probably_damaging(0.961) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
TNNT3 | SNV | Missense_Mutation | novel | c.41N>G | p.Glu14Gly | p.E14G | P45378 | protein_coding | deleterious_low_confidence(0.05) | probably_damaging(0.969) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TNNT3 | SNV | Missense_Mutation | rs867571200 | c.253N>A | p.Glu85Lys | p.E85K | P45378 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-EY-A1GK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TNNT3 | SNV | Missense_Mutation | novel | c.572T>C | p.Leu191Pro | p.L191P | P45378 | protein_coding | deleterious(0.01) | probably_damaging(0.986) | TCGA-EY-A214-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | SD |
TNNT3 | SNV | Missense_Mutation | c.299N>A | p.Arg100His | p.R100H | P45378 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-FI-A2D6-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TNNT3 | SNV | Missense_Mutation | rs778613532 | c.565G>A | p.Asp189Asn | p.D189N | P45378 | protein_coding | deleterious(0.01) | possibly_damaging(0.882) | TCGA-QF-A5YS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7140 | TNNT3 | NA | activator | CHEMBL3039529 | TIRASEMTIV |
Page: 1 |